Concepedia

Publication | Open Access

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

DOIFull Paper Access

5.3K

Citations

12

References

2005

Year

Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman,
New England Journal of Medicine

Abstract

Trastuzumab combined with paclitaxel after doxorubicin and cyclophosphamide improves outcomes among women with surgically removed HER2-positive breast cancer. (ClinicalTrials.gov numbers, NCT00004067 and NCT00005970.)

References

YearCitations

Page 1